Profil
Camille Lee worked as Senior Vice President-Alzheimer Therapeutic Area at Biogen, Inc. from 2017 to 2018.
Prior to that, she was Vice President-Diabetes Marketing at Novo Nordisk, Inc. in 2013.
She also held the position of Vice President-International Marketing at Zürichsee Druckereien AG.
Ms. Lee earned an undergraduate degree from The California State University and an MBA from Scandinavian International Management Institute.
Anciens postes connus de Camille Lee
Sociétés | Poste | Fin |
---|---|---|
BIOGEN INC. | Corporate Officer/Principal | 01/12/2018 |
Zürichsee Druckereien AG
Zürichsee Druckereien AG Publishing: NewspapersConsumer Services Zürichsee Druckereien AG is a printing private company based in Stäfa, Switzerland. Zürichsee Druckereien AG specializes in providing tailored communication solutions to help businesses succeed. The Swiss company's expertise lies in creating visually appealing designs with intuitive user interfaces that focus on effective communication. The company is particularly skilled in the area of networked communication. The company was acquired by FO Print & Media AG from Zürichsee Medien AG on November 29, 2010. | Sales & Marketing | - |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Public Communications Contact | - |
Formation de Camille Lee
The California State University | Undergraduate Degree |
Scandinavian International Management Institute | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOGEN INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Zürichsee Druckereien AG
Zürichsee Druckereien AG Publishing: NewspapersConsumer Services Zürichsee Druckereien AG is a printing private company based in Stäfa, Switzerland. Zürichsee Druckereien AG specializes in providing tailored communication solutions to help businesses succeed. The Swiss company's expertise lies in creating visually appealing designs with intuitive user interfaces that focus on effective communication. The company is particularly skilled in the area of networked communication. The company was acquired by FO Print & Media AG from Zürichsee Medien AG on November 29, 2010. | Consumer Services |